跳至主要内容
临床试验/EUCTR2016-002197-13-ES
EUCTR2016-002197-13-ES进行中(未招募)1 期

IMPLICATION OF TWO ANESTHETIC TECHNIQUES: SEVOFLURANE VERSUS PROPOFOL TO REDUCE BLOOD LOSS IN ORTHOGNATHIC SURGERY

Servicio de Anestesiología y Reanimación0 个研究点开始时间: 2016年10月26日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients = 18 and = 65 years old.
  • Classification ASA (American Society of Anesthesiologists) I or II.
  • orthognathic surgery scheduled bimaxillary
  • Signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients who do not wish to consent to participate in the study.
  • Hemodynamic instability determined by the need for continuous infusion of inotropic or vasopressor.
  • Severe heart disease (Grades III and IV, NYHA)
  • Kidney disease (creatinine clearance = 30 mL / min)
  • Liver disease (Grade C Child-Pugh).
  • Diabetes Mellitus Type I or II compensated or decompensated.
  • Previous surgery in the surgical field including orthognathic surgery.
  • Patients with treatments or diseases affecting the coagulation cascade or platelet aggregation.

研究者

发起方
Servicio de Anestesiología y Reanimación

相似试验